Novel CLL drugs could greatly increase costsNovember 22, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
ALL subtype ‘highly prevalent’ in adultsNovember 22, 2016Leukemia, Myelodysplasia, TransplantationALL
Large-scale tumor profiling deemed feasible, but challenges remainNovember 20, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersRelated Issues
Compound could treat leukemia, other cancersNovember 17, 2016Leukemia, Myelodysplasia, Transplantation
Team develops model of common infant ALLNovember 16, 2016Leukemia, Myelodysplasia, TransplantationPediatricsALL
Company withdraws application for eryaspase in ALLNovember 16, 2016Leukemia, Myelodysplasia, TransplantationPharmacyALL
EMA recommends orphan status for drug in AMLNovember 15, 2016Leukemia, Myelodysplasia, TransplantationPharmacyAML
FDA grants priority review for midostaurinNovember 15, 2016CythemiasLeukemia, Myelodysplasia, TransplantationPharmacyAML
CHMP recommends expanding use of drug in CLLNovember 11, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
NCCN issues challenge to ‘bag’ vincristineNovember 11, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersHematology Nursing
Tool provides info for cancer patients, survivorsNovember 10, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaRelated Issues
Panobinostat might treat high-risk ALL subtypeNovember 9, 2016Leukemia, Myelodysplasia, TransplantationPediatricsALL
Combating drug resistance in FLT3-mutated AMLNovember 6, 2016Leukemia, Myelodysplasia, TransplantationAML
Combine flow and HTS for sensitive MRD detection in CLL, speaker saysNovember 4, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma